Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens
-
Published:2021-04
Issue:2
Volume:19
Page:125-134
-
ISSN:1558-7673
-
Container-title:Clinical Genitourinary Cancer
-
language:en
-
Short-container-title:Clinical Genitourinary Cancer
Author:
Do Olivia A.ORCID, Ferris Lorin A., Holt Sarah K., Ramos Jorge D., Harshman Lauren C., Plimack Elizabeth R., Crabb Simon J.ORCID, Pal Sumanta K., De Giorgi Ugo, Ladoire Sylvain, Baniel Jack, Necchi Andrea, Vaishampayan Ulka N.ORCID, Bamias Aristotelis, Bellmunt Joaquim, Srinivas Sandy, Dorff Tanya B., Galsky Matt D., Yu Evan Y.
Funder
Bayer Sotio Bristol-Myers Squib Merck Takeda Dendreon Valient Jannsen Medivation Astellas Genentech Pfizer Endocyte Novartis BMS AstraZeneca Peloton Roche Sanofi Ipsen Janssen Clovis Oncology Astex Pharmaceuticals Incyte Merck Sharp & Dohme Janssen Pharmaceuticals Exelixis Bristol-Myers Squibb Blue Earth Daiichi-Sankyo Pharmacyclics Seattle Genetics Taiho
Reference22 articles.
1. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;Griffiths;J Clin Oncol,2011 2. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer;Zargar;Eur Urol,2015 3. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology;Flaig;J Natl Compr Canc Netw,2020 4. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline;Chang;J Urol,2017 5. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial;Birtle;Lancet,2020
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|